Cognizant vs UnitedHealth Group

Cognizant Expands AI-Enabled DevOps Capabilities for Gilead Sciences

Cognizant announced a five-year extension of its work with Gilead Sciences, a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades.

Cognizant Selected by SITA for AI-Led Cloud Finance Transformation

Cognizant (Nasdaq: CTSH) has been selected by SITA, a leading air transport technology provider, as the implementation partner for SITA's SKY program. This enterprise-wide, finance-led initiative aims to implement a modern cloud platform for finance, procurement, and supply chain processes across SITA's global operations in over 200 countries, using Oracle Fusion Cloud as the core ERP. Cognizant will apply its AI-first approach, leveraging expertise from more than 800 cloud ERP projects and custom agents built on its agentic AI capabilities to automate and enhance planning, forecasting, and everyday financial activities. The partnership is designed to transform SITA's finance function into a strategic, growth-oriented partner, optimizing resources and accelerating decision-making, with the announcement made on October 6, 2026.

• Cognizant selected as partner for SITA's SKY program for finance transformation (announced Oct 6, 2026).
• Initiative implements cloud ERP for finance, procurement, and supply chain across 200+ countries.
• Oracle Fusion Cloud serves as the core ERP platform.

10-Q Financial Filing Analysis for Cognizant (2026-07-29)

Cognizant Technology Solutions reported financial results for Q2 2026, delivering quarterly revenues of $5.48 billion, representing a 4.5% year-over-year increase (4.1% in constant currency). Revenue expansion was supported by large deal ramp-ups, growing demand in AI, analytics, and intuitive operations, as well as inorganic contributions from recent acquisitions including 3Cloud and Astreya Partners. Operating income grew 7.0% year-over-year to $874 million, yielding an operating margin of 15.9%, bolstered by operational efficiencies and foreign currency tailwinds, offset by compensation increases and dilution from acquisitions. During the quarter, Cognizant launched 'Project Leap', a multi-faceted restructuring initiative designed to accelerate AI-enabled delivery and optimize workforce productivity, incurring $84 million in restructuring charges with anticipated total program costs of $230 million to $320 million in 2026. This was counterbalanced by an $81 million reversal of an India Defined Contribution Obligation liability. The company also returned substantial capital to shareholders, repurchasing $1.15 billion in Class A common stock during the quarter.

• Q2 2026 revenues reached $5,481 million, up 4.5% YoY (4.1% constant currency), driven by strong Financial Services growth of 12.0% YoY to $1,733 million.
• GAAP operating income increased to $874 million (15.9% margin), impacted by $84 million in Project Leap restructuring costs and an offsetting $81 million SG&A benefit from the reversal of an Indian labor obligation liability.
• Capital allocation remained aggressive with $1.153 billion deployed into share repurchases in Q2 ($500 million via ASR) and completion of the Astreya acquisition for $634 million net of cash acquired, supported by drawing $1.0 billion on the revolving credit facility.

UnitedHealth Group Announces Addition to Leadership Team

UnitedHealth Group announced the addition to its leadership team in a press release dated Sep 24, 2026. The newsroom also features a new press release about UnitedHealthcare expanding access to child and family behavioral coaching to 13 million commercial members, and an announcement of the Q3 earnings release date.